Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Peramivir (Rapivab, adults) - selected U.S. labeling
Product / population
Adult uncomplicated influenza with no more than 2 days of symptoms; intravenous peramivir. Institutional repeated dosing is a separately labeled alternative, not the single-dose label course.
Renal method
Cockcroft-Gault CrCl mL/min; explicitly specified in label Table 1.
Source revision
Label revision date not separately recorded; retrieval date is not the revision date.
Retrieved
2026-09-05
Local review status
Selected dosing/renal sections read; concise local summary, not full prescribing information.
Official
Peramivir (Rapivab, adults) - selected U.S. labeling
U.S. product labeling / DailyMed · Adult uncomplicated influenza with no more than 2 days of symptoms; intravenous peramivir. Institutional repeated dosing is a separately labeled alternative, not the single-dose label course.
Renal method: Cockcroft-Gault CrCl mL/min; explicitly specified in label Table 1. Source date: Label revision date not separately recorded; retrieval date is not the revision date. Retrieved: 2026-09-05
Selected dosing/renal sections read; concise local summary, not full prescribing information.
Use Cockcroft-Gault CrCl for the adult table. In chronic hemodialysis, give the renal-adjusted dose after dialysis. The label table does not supply a separate below-10 non-dialysis dose.
RDM31-peramivir-label-renal · Source locator: 2.2
Selected warnings and limits
This single-dose label indication should not be conflated with institutional daily treatment for severe illness. Review serious skin/hypersensitivity and neuropsychiatric warnings.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.